Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited. more
Time Frame | UPC | Sector | S&P500 |
---|---|---|---|
1-Week Return | -17.43% | -2.12% | -3% |
1-Month Return | -65.57% | -3.42% | -0.73% |
3-Month Return | -85.56% | -11.13% | 2.87% |
6-Month Return | -98.17% | -5.74% | 7.17% |
1-Year Return | -96.37% | 3.97% | 25.31% |
3-Year Return | -97.46% | 1.05% | 28.38% |
5-Year Return | -99.11% | 34.37% | 81.89% |
Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 33.23M | 30.70M | 47.98M | 40.14M | 32.31M | [{"date":"2019-09-30","value":69.25,"profit":true},{"date":"2020-09-30","value":63.99,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":83.66,"profit":true},{"date":"2023-09-30","value":67.34,"profit":true}] |
Cost of Revenue | 19.82M | 16.61M | 22.66M | 18.25M | 21.99M | [{"date":"2019-09-30","value":87.49,"profit":true},{"date":"2020-09-30","value":73.32,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":80.56,"profit":true},{"date":"2023-09-30","value":97.08,"profit":true}] |
Gross Profit | 13.41M | 14.09M | 25.33M | 21.89M | 10.32M | [{"date":"2019-09-30","value":52.94,"profit":true},{"date":"2020-09-30","value":55.65,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":86.44,"profit":true},{"date":"2023-09-30","value":40.73,"profit":true}] |
Gross Margin | 40.35% | 45.90% | 52.78% | 54.53% | 31.93% | [{"date":"2019-09-30","value":73.99,"profit":true},{"date":"2020-09-30","value":84.17,"profit":true},{"date":"2021-09-30","value":96.79,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":58.55,"profit":true}] |
Operating Expenses | 3.36M | 3.74M | 11.74M | 28.91M | 13.84M | [{"date":"2019-09-30","value":11.61,"profit":true},{"date":"2020-09-30","value":12.95,"profit":true},{"date":"2021-09-30","value":40.59,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":47.88,"profit":true}] |
Operating Income | 9.75M | 10.25M | 13.59M | (7.02M) | (3.53M) | [{"date":"2019-09-30","value":71.76,"profit":true},{"date":"2020-09-30","value":75.44,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-51.65,"profit":false},{"date":"2023-09-30","value":-25.95,"profit":false}] |
Total Non-Operating Income/Expense | (229.03K) | (275.05K) | (13.27K) | (707.75K) | (479.59K) | [{"date":"2019-09-30","value":-22903500,"profit":false},{"date":"2020-09-30","value":-27505200,"profit":false},{"date":"2021-09-30","value":-1326600,"profit":false},{"date":"2022-09-30","value":-70774900,"profit":false},{"date":"2023-09-30","value":-47958800,"profit":false}] |
Pre-Tax Income | 9.65M | 10.10M | 13.68M | (7.98M) | (3.85M) | [{"date":"2019-09-30","value":70.57,"profit":true},{"date":"2020-09-30","value":73.84,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-58.37,"profit":false},{"date":"2023-09-30","value":-28.14,"profit":false}] |
Income Taxes | 2.10M | 2.54M | 2.36M | 752.42K | 2.31M | [{"date":"2019-09-30","value":82.67,"profit":true},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":92.77,"profit":true},{"date":"2022-09-30","value":29.6,"profit":true},{"date":"2023-09-30","value":91,"profit":true}] |
Income After Taxes | 7.55M | 7.56M | 11.32M | (8.74M) | (6.16M) | [{"date":"2019-09-30","value":66.71,"profit":true},{"date":"2020-09-30","value":66.77,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-77.18,"profit":false},{"date":"2023-09-30","value":-54.44,"profit":false}] |
Income From Continuous Operations | 7.55M | 7.56M | 11.32M | (8.74M) | (6.16M) | [{"date":"2019-09-30","value":66.71,"profit":true},{"date":"2020-09-30","value":66.77,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-77.18,"profit":false},{"date":"2023-09-30","value":-54.44,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}] |
Net Income | 7.55M | 7.56M | 11.32M | (8.74M) | (6.16M) | [{"date":"2019-09-30","value":66.71,"profit":true},{"date":"2020-09-30","value":66.77,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-77.18,"profit":false},{"date":"2023-09-30","value":-54.44,"profit":false}] |
EPS (Diluted) | 0.50 | 0.70 | - | - | - | [{"date":"2019-09-30","value":72.17,"profit":true},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
UPC | |
---|---|
Cash Ratio | 0.55 |
Current Ratio | 1.63 |
Quick Ratio | 1.44 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
UPC | |
---|---|
ROA (LTM) | -5.65% |
ROE (LTM) | -50.22% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
UPC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.46 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.54 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
UPC | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.05 |
P/B | 0.05 |
Price/FCF | NM |
EV/R | 0.02 |
EV/Ebitda | 0.31 |
Universe Pharmaceuticals Inc (UPC) share price today is $0.637
Yes, Indians can buy shares of Universe Pharmaceuticals Inc (UPC) on Vested. To buy Universe Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in UPC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Universe Pharmaceuticals Inc (UPC) via the Vested app. You can start investing in Universe Pharmaceuticals Inc (UPC) with a minimum investment of $1.
You can invest in shares of Universe Pharmaceuticals Inc (UPC) via Vested in three simple steps:
The 52-week high price of Universe Pharmaceuticals Inc (UPC) is $64.8. The 52-week low price of Universe Pharmaceuticals Inc (UPC) is $0.61.
The price-to-earnings (P/E) ratio of Universe Pharmaceuticals Inc (UPC) is
The price-to-book (P/B) ratio of Universe Pharmaceuticals Inc (UPC) is 0.05
The dividend yield of Universe Pharmaceuticals Inc (UPC) is 0.00%
The market capitalization of Universe Pharmaceuticals Inc (UPC) is $1.44M
The stock symbol (or ticker) of Universe Pharmaceuticals Inc is UPC